Clinical Trials Sponsored by Neurogen Corporation

Total 6637 results

Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

Early Parkinson Disease

United States
Neurogen Corporation

Terminated

Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

Primary Insomnia

United States
Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States
Neurogene Inc.

Recruiting

A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)

Ceroid Lipofuscinosis, Neuronal 5

United States
Neurogene Inc.

Terminated

A Natural History Study of Aspartylglucosaminuria (AGU)

Lysosomal Storage Diseases | Aspartylglucosaminuria | Aspartylglucosamidase (AGA) Deficiency

United States
Neurogene Inc.

Recruiting

A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome

Rett Syndrome

United States
Neurogene Inc.

Terminated

A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J) (CMT4J)

Charcot-Marie-Tooth Disease | Hereditary Motor and Sensory Neuropathy IV

United States
Neurogene Inc.

Recruiting

Gene Therapy Study for Children With CLN5 Batten Disease (CLN5-200)

Neuronal Ceroid Lipofuscinosis CLN5

United States, United Kingdom
NeurogesX

Completed

Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)

Postherpetic Neuralgia

United States
NeurogesX

Completed

Effect of NGX-4010 on ENFD and Sensory Function

Human Volunteers

United States
NeurogesX

Completed

NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Shingles

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases

United States
NeurogesX

Completed

Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function

Pain
NeurogesX

Terminated

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases
NeurogesX

Completed

A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers

Pain

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Shingles
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Shingles
NeurogesX

Unknown

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

HIV Infections

United States
NeurogesX

Completed

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster

United States
NeurogesX

Terminated

An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

HIV Infections | Pain | Diabetes Mellitus | Diabetic Neuropathies | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Polyneuropathies
Neurogen Brain and Spine Institute

Withdrawn

Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury

Spinal Cord Injury

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Muscular Dystrophy

Muscular Dystrophy

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Mental Retardation

Mental Retardation

India
Neurogen Brain and Spine Institute

Withdrawn

Cell Therapy as Treatment for Cerebral Palsy

Cerebral Palsy

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Spinal Cord Injury

Spinal Cord Injury

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy

India
NeurogesX

Completed

Study of NGX-1998 for the Treatment of Postherpetic Neuralgia

Pain | Postherpetic Neuralgia

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

HIV Infections | Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster
NeurogesX

Completed

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster

United States
NeurogesX

Completed

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

HIV Infections | Pain | Diabetes Mellitus | Diabetic Neuropathies | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Polyneuropathies

United States
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Autism Spectrum Disorders

Autism Spectrum Disorders

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy for Cerebral Palsy

Cerebral Palsy

India
Neurogen Brain and Spine Institute

Withdrawn

Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Traumatic Brain Injury

Traumatic Brain Injury

India
Neurogen Brain and Spine Institute

Withdrawn

Autologous Stem Cell Therapy in Stroke

Stroke

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Incurable Neurological Disorders

Neurological; Disorder, Nervous System

India
Neurogen Brain and Spine Institute

Withdrawn

Cell Therapy in Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy

India
Neurogen Brain and Spine Institute

Withdrawn

Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke

Cerebrovascular Accident

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

India
Neuromed IRCCS

Recruiting

Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain.

Drug Resistant Epilepsy

Italy
Neuromed IRCCS

Not yet recruiting

Compassion Program for Parkinson

Parkinson Disease
Neuromed IRCCS

Recruiting

Mediterranean Diet on Pregnancy and Foetus Development

Infant Development | Fetal Development | Pregnancy Outcomes

Italy
Neuromed IRCCS

Recruiting

Neurophysiological Evaluation of Muscle Tone

Spasticity, Muscle | Muscle Tone Abnormalities | Rigidity, Muscle

Italy
Neuromed IRCCS

Not yet recruiting

Assessment of the Possible Association Between Left Ventricular Diastolic Dysfunction and Carotid Atherosclerosis and Brain White Matter Damage

Left Ventricular Diastolic Dysfunction
Neuromed IRCCS

Recruiting

Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis

Italy
Neuromed IRCCS

Recruiting

Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process

Carotid Atherosclerosis

Italy
Neuromed IRCCS

Recruiting

Cognitive Abilities in Brain Damaged Patients (Cog)

Brain Damage

Italy
Neuromed IRCCS

Recruiting

Noninvasive Brain Stimulation Training (TrainingNIBS)

Brain Injuries

Italy

Clinical Trials Sponsored by Neurogen Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations